Bakker WW - Search Results

1

Altered activity of plasma hemopexin in patients with minimal change disease in relapse.

Bakker WW, van Dael CM, Pierik LJ, van Wijk JA, Nauta J, Borghuis T, Kapojos JJ. Bakker WW, et al. Pediatr Nephrol. 2005 Oct;20(10):1410-5. doi: 10.1007/s00467-005-1936-3. Epub 2005 Aug 4. Pediatr Nephrol. 2005. PMID: 16079987

2

Regulation of plasma hemopexin activity by stimulated endothelial or mesangial cells.

Kapojos JJ, Poelstra K, Borghuis T, Banas B, Bakker WW. Kapojos JJ, et al. Among authors: bakker ww. Nephron Physiol. 2004;96(1):P1-10. doi: 10.1159/000075574. Nephron Physiol. 2004. PMID: 14752238

3

Protease activity of plasma hemopexin.

Bakker WW, Borghuis T, Harmsen MC, van den Berg A, Kema IP, Niezen KE, Kapojos JJ. Bakker WW, et al. Kidney Int. 2005 Aug;68(2):603-10. doi: 10.1111/j.1523-1755.2005.00438.x. Kidney Int. 2005. PMID: 16014037 Free article.

4

Production of hemopexin by TNF-alpha stimulated human mesangial cells.

Kapojos JJ, van den Berg A, van Goor H, te Loo MW, Poelstra K, Borghuis T, Bakker WW. Kapojos JJ, et al. Among authors: bakker ww. Kidney Int. 2003 May;63(5):1681-6. doi: 10.1046/j.1523-1755.2003.00907.x. Kidney Int. 2003. PMID: 12675843 Free article.

5

Enhanced ecto-apyrase activity of stimulated endothelial or mesangial cells is downregulated by glucocorticoids in vitro.

Kapojos JJ, van den Berg A, Borghuis T, Banas B, Huitema S, Poelstra K, Bakker WW. Kapojos JJ, et al. Among authors: bakker ww. Eur J Pharmacol. 2004 Oct 6;501(1-3):191-8. doi: 10.1016/j.ejphar.2004.08.008. Eur J Pharmacol. 2004. PMID: 15464078

6

Plasma hemopexin activity in pregnancy and preeclampsia.

Bakker WW, Donker RB, Timmer A, van Pampus MG, van Son WJ, Aarnoudse JG, van Goor H, Niezen-Koning KE, Navis G, Borghuis T, Jongman RM, Faas MM. Bakker WW, et al. Hypertens Pregnancy. 2007;26(2):227-39. doi: 10.1080/10641950701274896. Hypertens Pregnancy. 2007. PMID: 17469012

7

Vascular contraction and preeclampsia: downregulation of the Angiotensin receptor 1 by hemopexin in vitro.

Bakker WW, Henning RH, van Son WJ, van Pampus MG, Aarnoudse JG, Niezen-Koning KE, Borghuis T, Jongman RM, van Goor H, Poelstra K, Navis G, Faas MM. Bakker WW, et al. Hypertension. 2009 Jun;53(6):959-64. doi: 10.1161/HYPERTENSIONAHA.108.127951. Epub 2009 May 4. Hypertension. 2009. PMID: 19414647

8

High plasma hemopexin activity is an independent risk factor for late graft failure in renal transplant recipients.

Krikken JA, van Ree RM, Klooster A, Seelen MA, Borghuis T, Lems SP, Schouten JP, Bakker WW, Gans RO, Navis G, Bakker SJ. Krikken JA, et al. Among authors: bakker sj, bakker ww. Transpl Int. 2010 Aug;23(8):805-12. doi: 10.1111/j.1432-2277.2010.01055.x. Epub 2010 Feb 9. Transpl Int. 2010. PMID: 20149159 Free article.

9

Plasma hemopexin as a potential regulator of vascular responsiveness to angiotensin II.

Bakker WW, Spaans F, el Bakkali L, Borghuis T, van Goor H, van Dijk E, Buijnink J, Faas MM. Bakker WW, et al. Reprod Sci. 2013 Mar;20(3):234-7. doi: 10.1177/1933719112446081. Epub 2012 May 17. Reprod Sci. 2013. PMID: 22598486 Review.

10

Hemopexin activity is associated with angiotensin II responsiveness in humans.

Krikken JA, Lely AT, Bakker SJ, Borghuis T, Faas MM, van Goor H, Navis G, Bakker WW. Krikken JA, et al. Among authors: bakker ww. J Hypertens. 2013 Mar;31(3):537-41; discussion 542. doi: 10.1097/HJH.0b013e32835c1727. J Hypertens. 2013. PMID: 23254305

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

91 results

Search Page